ClinConnect ClinConnect Logo
Search / Trial NCT04538339

Prediction of Arterial Lactate and Blood Gas Values Through the Analysis of Central Venous Blood

Launched by CENTRE HOSPITALIER RÉGIONAL D'ORLÉANS · Aug 29, 2020

Trial Information

Current as of May 27, 2025

Completed

Keywords

Lactate Arterial Blood Gas Central Venous Blood Gazometer

ClinConnect Summary

Mathematical models for predicting arterial blood gas and arterial lactate have recently be published (PMID 27543529; see the citations section). The aim of the study is to externally validate these models in a multicenter (11 centres in France) cohort of intensive care unit patients suffering from acute circulatory failure. For the peru pose of the study, patients will undergo concomitent central venous/arterial blood sampling from 1 to 4 times during their intensive cafe unit stay. Clinical characteristics of the patients and central venous blood gas and lactate values will be used to pre...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • age\>18 years
  • patient admitted in a intensive care unit
  • patient already carrying an indwelling arterial catheter and a superior vena cava central catheter
  • patient presenting an acute circulatory failure defined by the presence of at least two of the following items: a) Persistent hypotension (systolic arterial blood pressure \< 90 mm Hg or mean arterial pressure \< 65 mm Hg) or need for continuous intravenous vasopressor treatment (at any dose). b) Presence of at least one of the following signs of hypoperfusionfusion :Change in mental status ; Skin mottling ; Oliguria (Urine output \<0.5 ml/kg body weight for at least one hour); Arterial lactate \> 2 mmol/l or peripheral venous lactate \> 3.2 mmol/l; ScvO2 \<70%.
  • Routine medical management requires central venous blood sampling for ScvO2 measurement and arterial blood sampling for gazometry.
  • Exclusion Criteria:
  • Opposition to participation in the study
  • Impossibility to take a concomitant arterial and venous gazometric sample.
  • Patient treated with ECMO (extracorporeal membrane,oxygrnation), intermittent dialysis or continuous dialysis during sampling
  • Patient hospitalized without consent and/or deprived of liberty by court decision.

About Centre Hospitalier Régional D'orléans

The Centre Hospitalier Régional d'Orléans is a leading healthcare institution dedicated to advancing medical research and improving patient care through innovative clinical trials. Located in Orléans, France, the center is committed to fostering a collaborative environment that integrates clinical expertise with cutting-edge research methodologies. By facilitating multidisciplinary studies across various therapeutic areas, the Centre Hospitalier Régional d'Orléans aims to enhance treatment protocols and contribute to the global body of medical knowledge, ultimately benefiting patients and the healthcare community at large.

Locations

Nantes, , France

Marseille, , France

Angers, , France

Dijon, , France

Limoges, , France

Orléans, , France

Strasbourg, , France

Poitiers, , France

Garches, , France

Versailles, , France

Patients applied

0 patients applied

Trial Officials

Toufik Kamel, MD

Principal Investigator

CHR Orléans, France

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials